key: cord-0893011-nxry2y50 authors: Eisenberg, Matthew; Tingey, Christopher; Fulton, Oliver; Owen, Josh; Snyder, Travis title: Quadrilateral space region inflammation and other incidental findings on shoulder MRI following recent COVID-19 vaccination: Three case reports date: 2021-07-19 journal: Radiol Case Rep DOI: 10.1016/j.radcr.2021.07.028 sha: 1b6424e4e25887e118ec8b211623d7ca9e4e874f doc_id: 893011 cord_uid: nxry2y50 We present 3 cases reporting the normal appearance of the post COVID-19 vaccination on shoulder MRI exams. All three patients were imaged 1-5 days post-vaccination for unrelated MSK shoulder symptoms, and none reported any symptoms besides mild shoulder discomfort for a day or two following vaccine administration. All three patients demonstrated characteristic deltoid edema, quadrilateral space region edema and axillary nodal prominence. Vessel prominence with T2 and T1 increased signal draining to the approximate location of the quadrilateral space and axilla was an associated feature. The normal appearance of the COVID-19 vaccine on shoulder MRI has not been previously described, and recognition by the radiologist will prevent erroneous differential diagnosis, unnecessary medical workups, and detract from the clinically relevant pathological imaging findings in patients with shoulder pain. Millions of COVID-19 vaccination doses have already been delivered and administered in the United States [1], most commonly into the belly of the deltoid muscle [2] [3] [4] [5] . The most common reported side effect is pain at the injection site (77.8%) followed by swelling (6.3%) and redness (5.9%), which are typically mild and transient [2] . Serious side effects are very unusual. Unliteral axillary adenopathy (and less commonly cervical adenopathy) has been reported following COVID vaccination, causing a particular diagnostic dilemma for breast radiologists and oncologists [6] . This axillary adenopathy has been estimated to generally resolved in 5 weeks [7] . However, the reported studies are often small studies and generally discuss patients imaged greater than a week following vaccine administration. Imaging features of the COVID-19 vaccine on shoulder MRI have not been described. We present the imaging appearance of this vaccine injection in 3 patients; all imaged less than five days from vaccine administration. Characteristic features may allow the radiologist to diagnose or suggest a vaccine-related inflammatory reaction even in the absence of this relevant history. A 21-year-old male with a history of right-sided shoulder pain acquired from old hockey injuries with persistent clicking obtained an MRI of his right shoulder 24 hours after receiving the second dose of his Pfizer-BioNTech Covid-19 vaccination in the right shoulder. The patient reported that 15 hours after his vaccination he noticed swelling anteriorly towards the axilla and some mild swelling of cervical lymph nodes. There was mild tenderness without discoloration. overlying the deltoid injection site. These injection symptoms subsided in two days. See figure 1 for images and associated findings. A 26-year-old female received her 1 st Pfizer-BioNTech Covid-19 vaccination four days before a left shoulder MRI for pain following an MVC 7 days prior. She reported only mild injection symptoms without any adenopathy that she noticed. On one-month follow-up, she again reported no axillary swelling or any deltoid pain. See figure 2 for images and associated findings. A 34-year-old female received her second dose of the Pfizer-BioNTech COVID-19 vaccination five days before imaging for shoulder pain following an MVC 3 weeks prior. She reported some limited range of motion and mild shoulder pain following the MVC. She reported mild deltoid discomfort for 'a day or two' following the vaccination, but no symptoms she could relate to the injection at the time of imaging or on a follow-up call. See figure 3 for images and associated findings. Axillary and cervical lymphadenopathy has been well described in patients receiving the COVID-19 vaccine [8, 9] . Rare shoulder complications of the COVID-19 vaccine include myositis, calcific myositis, and subacromial-subdeltoid bursitis [10] [11] [12] . These complications have been previously described in pre-COVID vaccinations administration and have been termed 'shoulder injury related to vaccine administration' (SIRVA) [13] . No imaging features of these complications were present in our subjects. Quadrilateral space region edema and inflammation following COVID injection has, to our knowledge, not been previously described and the approximate location of the quadrilateral space appears to be the intermediary station for lymphatic/venous drainage before extension to the axilla. There is a paucity of literature on lymphatic drainage of the right upper extremity and particularly of the deltoid [14] . The adjacent triangular intramuscular space has been described as a lymphatic station for upper back melanoma metastasis [15] . It is possible the inflammation we have described as centered in the quadrilateral space involves some of the adjacent spaces as definitive boundaries may be challenging by imaging. In our reported cases, patient 1 was [16, 17] . All three patients demonstrated vessel prominence with increased T2 and unusual ill-defined increased T1 signal in some of the larger vessels extending from the deltoid region to the approximate region of the quadrilateral space. (Figures 1-3) All three patients demonstrated diffuse increased T2 signal in the deltoid muscle consistent with edema/inflammation and the direct injection of the COVID vaccine (Figures 1-3 ). Imaging features of this vaccine inflammatory reaction in the deltoid could be erroneously interpreted as strain, tear, myositis, or denervation injury, depending on the imaging pattern. This edema tracked to the approximate location of the quadrilateral space, where all three demonstrated considerable edema/inflammation (Figures 1-3) . Imaging features of the inflammatory vaccine reaction in the approximate location of the quadrilateral space and axilla and associated lymphatics/vessels could be misinterpreted as regional muscle strain, DVT, brachial plexus injury, neoplasm, or nonspecific infectious/inflammatory conditions depending on imaging features [18, 19] . With the millions of doses that have already been given and are continuing to increase each day, it is essential for radiologists to recognize the normal shoulder and axillary MRI appearance of patients who have recently received the COVID-19 vaccination to avoid further unnecessary testing and subtract from the actual underlying pathology in shoulders presenting with shoulder pain. This study may also add to the existing literature on deltoid lymphatic drainage. COVID-19 Vaccinations in the United States COVID-19 Vaccine EUA Amendment Review Memorandum Moderna COVID-19 Vaccine VRBPAC Briefing Document Avoiding shoulder injury from intramuscular vaccines Safety Monitoring of the Janssen COVID-19 Vaccine COVID-19 Vaccination-Related Lymphadenopathy: What To Be Aware Of Evolution of Lymphadenopathy at PET/MRI after COVID-19 Vaccination Unilateral Axillary Lymphadenopathy After Coronavirus Disease (COVID-19) Vaccination Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review Subacromial-subdeltoid bursitis following COVID-19 vaccination: a case of shoulder injury related to vaccine administration (SIRVA) COVID-19 related calcific myositis cases COVID-19 vaccinerelated myositis Don't aim too high: Avoiding shoulder injury related to vaccine administration Deep lymphatic anatomy of the upper limb: An anatomical study and clinical implications A triangular intermuscular space sentinel node in melanoma: association with axillary lymphatic drainage Spatial distribution of oil depots monitored in human muscle using MRI The contribution of the invivo fate of an oil depot to drug absorption Diagnosing upper extremity deep vein thrombosis with non-contrast-enhanced Magnetic Resonance Direct Thrombus Imaging: A pilot study MR imaging of rotator cuff injury: what the clinician needs to know We would like to acknowledge Jean Jose D.O. for going above and beyond the standard in training MSK radiologists. Written informed consent was obtained by all patients present in study.